Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GEMIN8P4, or gem nuclear organelle associated protein 8 pseudogene 4, is a processed pseudogene related to the parental GEMIN8 gene. Pseudogenes like GEMIN8P4 arise from retrotransposition or other mutational events, resulting in a non-functional genomic sequence that closely resembles a protein-coding gene, but which typically lacks protein-coding potential due to damaging mutations or lack of regulatory sequences[3]. Unlike functional genes, pseudogenes such as GEMIN8P4 do not produce active protein products, and there is no evidence that this particular pseudogene exerts regulatory or biological effects. It is not considered a therapeutic target, and there are no known drugs, disease associations, or clinical utility as a biomarker[1][3]. There is no evidence in the scientific literature that GEMIN8P4 encodes a protein, serves as a therapeutic target, or has any functional role in health or disease. The entry name and abbreviation are correctly given, but describing it as a target is incorrect, as it is a pseudogene and not a biologically active target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gem nuclear organelle associated protein 8 pseudogene 4 (GEMIN8P4).